Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma

di Guo, Hong-Qiang, Huang, Guo-Liang, Guo, Cheng-Cheng, Pu, Xing-Xiang, Lin, Tong-Yu
Pubblicazione 2010

EGFR inhibitors sensitize non–small cell lung cancer cells to TRAIL-induced apoptosis

di Xu, Fei, Tian, Ying, Huang, Yan, Zhang, Ling-Ling, Guo, Zheng-Zheng, Huang, Jia-Jia, Lin, Tong-Yu
Pubblicazione 2011

Efficacy of gemcitabine combined with oxaliplatin, L-asparaginase and dexamethasone in patients with newly-diagnosed extranodal NK/T-cell lymphoma

di GUO, HONG-QIANG, LIU, LEI, WANG, XIN-FENG, LIN, TONG-YU, YAO, SHU-NA, YAO, ZHI-HUA, YANG, SHU-JUN
Pubblicazione 2014

Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphom...

di Wang, Jing-hua, Wang, Liang, Liu, Cheng-cheng, Xia, Zhong-jun, Huang, Hui-qiang, Lin, Tong-yu, Jiang, Wen-qi, Lu, Yue
Pubblicato in Oncotarget (2016)

A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution

di Huang, Jia-Jia, Xia, Yi, Wang, Yu, Liu, Pan-Pan, Bi, Xi-Wen, Sun, Peng, Lin, Tong-Yu, Jiang, Wen-Qi, Li, Zhi-Ming
Pubblicato in Oncotarget (2016)

Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen

di Chen, Xing-Gui, Huang, He, Tian, Ying, Guo, Cheng-Cheng, Liang, Chao-Yong, Gong, Yao-Ling, Zou, Ben-Yan, Cai, Rui-Qing, Lin, Tong-Yu
Pubblicazione 2011

Expression of BAFF and BAFF-R in Follicular Lymphoma: Correlation with Clinicopathologic Characteristics and Survival Outcomes

di Li, Ya-Jun, Jiang, Wen-Qi, Rao, Hui-Lan, Huang, Jia-Jia, Xia, Yi, Huang, Hui-Qiang, Lin, Tong-Yu, Xia, Zhong-Jun, Li, Su, Li, Zhi-Ming
Pubblicazione 2012

Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma

di Huang, Jia-Jia, Li, Ya-Jun, Xia, Yi, Wang, Yu, Wei, Wen-Xiao, Zhu, Ying-Jie, Lin, Tong-Yu, Huang, Hui-Qiang, Jiang, Wen-Qi, Li, Zhi-Ming
Pubblicazione 2013

Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis

di Song, Chen-Ge, Huang, Jia-Jia, Li, Ya-Jun, Xia, Yi, Wang, Yu, Bi, Xi-Wen, Jiang, Wen-Qi, Huang, Hui-Qiang, Lin, Tong-Yu, Li, Zhi-Ming
Pubblicato in PLoS One (2015)

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors

di Huang, JiaJia, Jiang, WenQi, Xu, RuiHua, Huang, HuiQiang, Lv, Yue, Xia, ZhongJun, Sun, XiaoFei, Guan, ZhongZhen, Lin, TongYu, Li, ZhiMing
Pubblicazione 2010

High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma

di Zhang, Xi, Huang, Jia-Jia, Xia, Yi, Li, Chao-Feng, Wang, Yu, Liu, Pan-Pan, Bi, Xi-Wen, Sun, Peng, Lin, Tong-Yu, Jiang, Wen-Qi, Li, Zhi-Ming
Pubblicato in Oncotarget (2016)

Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study

di Hu, Li-Yang, Xu, Xiao-Lu, Rao, Hui-Lan, Chen, Jie, Lai, Ren-Chun, Huang, Hui-Qiang, Jiang, Wen-Qi, Lin, Tong-Yu, Xia, Zhong-Jun, Cai, Qing-Qing
Pubblicato in Chin J Cancer (2017)

Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group

di Yoon, Dok Hyun, Cao, Junning, Chen, Tsai-Yun, Izutsu, Koji, Kim, Seok Jin, Kwong, Yok Lam, Lin, Tong Yu, Thye, Lim Soon, Xu, Bing, Yang, Deok Hwan, Kim, Won Seog
Pubblicato in J Hematol Oncol (2020)

New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

di Cai, Qing-Qing, Hu, Li-Yang, Geng, Qi-Rong, Chen, Jie, Lu, Zhen-Hai, Rao, Hui-Lan, Liu, Qing, Jiang, Wen-Qi, Huang, Hui-Qiang, Lin, Tong-Yu, Xia, Zhong-Jun
Pubblicato in Chin J Cancer (2016)

Serum C-Reactive Protein (CRP) as a Simple and Independent Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

di Li, Ya-Jun, Li, Zhi-Ming, Xia, Yi, Huang, Jia-Jia, Huang, Hui-Qiang, Xia, Zhong-Jun, Lin, Tong-Yu, Li, Su, Cai, Xiu-Yu, Wu-Xiao, Zhi-Jun, Jiang, Wen-Qi
Pubblicazione 2013

BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma

di Tian, Xiao‐Peng, Cai, Jun, Ma, Shu‐Yun, Fang, Yu, Huang, Hui‐Qiang, Lin, Tong‐Yu, Rao, Hui‐Lan, Li, Mei, Xia, Zhong‐Jun, Kang, Tie‐Bang, Xie, Dan, Cai, Qing‐Qing
Pubblicato in Cancer Commun (Lond) (2020)

Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

di Li, Zhi-Ming, Huang, Jia-Jia, Xia, Yi, Sun, Jian, Huang, Ying, Wang, Yu, Zhu, Ying-Jie, Li, Ya-Jun, Zhao, Wei, Wei, Wen-Xiao, Lin, Tong-Yu, Huang, Hui-Qiang, Jiang, Wen-Qi
Pubblicazione 2012

Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survi...

di Chen, Kai-Lin, Chen, Jie, Rao, Hui-Lan, Guo, Ying, Huang, Hui-Qiang, Zhang, Liang, Shao, Jian-Yong, Lin, Tong-Yu, Jiang, Wen-Qi, Zou, De-Hui, Hu, Li-Yang, Wirian, Michael Lucas, Cai, Qing-Qing
Pubblicato in Chin J Cancer (2015)

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer

di Xu, Da-zhi, Geng, Qi-rong, Tian, Ying, Cai, Mu-yan, Fang, Xin-juan, Zhan, You-qing, Zhou, Zhi-wei, Li, Wei, Chen, Ying-bo, Sun, Xiao-wei, Guan, Yuan-xiang, Li , Yuan-fang, Lin, Tong-yu
Pubblicazione 2010

Low initial trough concentration of rituximab is associated with unsatisfactory response of first-line R-CHOP treatment in patients with follicular lymphoma with grade 1/2

di Liu, Shu, Huang, He, Chen, Rong-xin, Wang, Zhao, Guan, Yan-ping, Peng, Chen, Fang, Xiao-jie, Chen, Zhuo-jia, Guan, Shao-xing, Zhu, Xia, Ren, Quan-guang, Yao, Yu-yi, Huang, Hong-bing, Huang, Min, Wang, Xue-ding, Lin, Tong-yu
Pubblicato in Acta Pharmacol Sin (2020)